Pharmacogenetics and drug metabolism : historical perspective and appraisal
The events leading up to the discovery of genetically controlled polymorphic metabolism of xenobiotics and pharmaceutical chemicals are briefly summarised with the salient historical features being emphasised. Especial attention has been given to seminal works in the then emerging field.The evolving knowledge of such polymorphic metabolism and its role in the quest for personalised medicine and the individualisation of patient drug therapy are appraised. Opinion is offered as to whether or not the full potential has been exploited and if the practical application of this information may be regarded as a success or failure within the present clinical arena.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Xenobiotica; the fate of foreign compounds in biological systems - 50(2020), 1 vom: 15. Jan., Seite 3-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Smith, Robert L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Drug metabolism |
|---|
| Anmerkungen: |
Date Completed 20.02.2020 Date Revised 20.02.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/00498254.2019.1668579 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM301329915 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM301329915 | ||
| 003 | DE-627 | ||
| 005 | 20231225104412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/00498254.2019.1668579 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1004.xml |
| 035 | |a (DE-627)NLM301329915 | ||
| 035 | |a (NLM)31524553 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Smith, Robert L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacogenetics and drug metabolism |b historical perspective and appraisal |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.02.2020 | ||
| 500 | |a Date Revised 20.02.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The events leading up to the discovery of genetically controlled polymorphic metabolism of xenobiotics and pharmaceutical chemicals are briefly summarised with the salient historical features being emphasised. Especial attention has been given to seminal works in the then emerging field.The evolving knowledge of such polymorphic metabolism and its role in the quest for personalised medicine and the individualisation of patient drug therapy are appraised. Opinion is offered as to whether or not the full potential has been exploited and if the practical application of this information may be regarded as a success or failure within the present clinical arena | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Pharmacogenetics | |
| 650 | 4 | |a drug metabolism | |
| 650 | 4 | |a genotype | |
| 650 | 4 | |a personalized medicine | |
| 650 | 4 | |a phenotype | |
| 650 | 7 | |a Xenobiotics |2 NLM | |
| 700 | 1 | |a Mitchell, Stephen C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Xenobiotica; the fate of foreign compounds in biological systems |d 1971 |g 50(2020), 1 vom: 15. Jan., Seite 3-8 |w (DE-627)NLM000064742 |x 1366-5928 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2020 |g number:1 |g day:15 |g month:01 |g pages:3-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/00498254.2019.1668579 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2020 |e 1 |b 15 |c 01 |h 3-8 | ||